RSL1D1 and colorectal carcinoma: In addition, RSL1D1 expression was greatly increased in primary tumors from CRC patients with distant metastases (P = 0.028, Fig. 1G), node metastases (P = 0.005, Supplementary Table 1) and an advanced clinical stage (P = 0.004, Fig. 1H).